Cleared Traditional

K152944 - Xscribe Stress Exercise Testing Systems, Q-Stress Stress Exercise Testing Systems

K152944 is an FDA 510(k) clearance for Xscribe Stress Exercise Testing Systems, manufactured by Mortara Instrument, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K152944 · Mortara Instrument, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
92d
Days
Class 2
Risk

K152944 is an FDA 510(k) clearance for the Xscribe Stress Exercise Testing Systems, Q-Stress Stress Exercise Testing Sys.... Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Mortara Instrument, Inc. (Milwaukee, US). The FDA issued a Cleared decision on January 6, 2016 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Mortara Instrument, Inc. devices

FDA 510(k) Submission Details - K152944

510(k) Number K152944 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 06, 2015
Decision Date January 06, 2016
Days to Decision 92 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 125d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 368
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K152944.
PC ECG
K161302 · Edan Instruments, Inc. · Jul 2016
Diagnostic Station DS20
K152043 · Schiller AG · May 2016
PC ECG
K152427 · Edan Instruments, Inc. · Feb 2016
ELI 380 ELECTROCARDIOGRAPH
K142105 · Mortara Instrument, Inc. · Sep 2014
DIGITAL ELECTROCARDIOGRAPH
K131858 · Guangdong Biolight Meditech Co., Ltd. · Jun 2014
SE-601 SERIES ELECTROCARDIOGRAPH
K131503 · Edan Instruments, Inc. · Feb 2014